[1] KHERA A V, KATHIRESAN S. Genetics of coronary artery disease: discovery, biology and clinical translation[J]. Nat Rev Genet, 2017,18(6):331-344. [2] 季宏,卞茸文.载脂蛋白E及其基因多态性与动脉粥样硬化研究进展[J]. 实用老年医学,2006,20(3):201-202.. [3] 吉娜, 郭治华.不同年龄段急性心肌梗死病人临床特点分析[J]. 实用老年医学,2018,32(7):630-633. [4] ANUURAD E, RUBIN J, LU G, et al. Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol[J]. J Lipid Res, 2006, 47(11):2475-2481. [5] ELMADBOUH I, ELGHOBASHY Y, ABD-ALLAH E, et al. Relationship of apolipoprotein E polymorphism with lipid profiles in atherosclerotic coronary artery disease[J]. Egypt Heart J,2013,65(2): 77-78. [6] XU M, ZHAO J, ZHANG Y, et al. Apolipoprotein e gene variants and risk of coronary heart disease: a meta-analysis. [J]. Biomed Res Int, 2016, 2016:3912175. [7] AFROZE D, YOUSUF A, TRAMBOO N A, et al. ApoE gene polymorphism and its relationship with coronary artery disease in ethnic Kashmiri population[J]. Clin Exp Med, 2016,16(4):551-556. [8] LI SS, YANG J, LI L S, et al. Apolipoprotein E polymorphism and the characteristics of diseased vessels in male Chinese patients with angiographic coronary artery disease: a case-case study[J]. Clin Cardiol, 2010,33(6): E30-E34. [9] CHEEMA A N, BHATTI A, WANG X, et al. APOE gene polymorphism and risk of coronary stenosis in Pakistani population[J]. Biomed Res Int, 2015, 2015:587465. |